Funding, News and Announcements

This clinician-scientist award program is a collaboration between the Canadian Lung Association (CLA), CIHR’s Institute of Circulatory and Respiratory Health (CIHR-ICRH) and AstraZeneca (AZ) Canada. The goal of the award is to support emerging clinician scientists (e.g., Doctor of Medicine, Doctor of Medicine–Doctor of Philosophy, Doctor of Dental Sciences, PhD–Respiratory Therapist, PhD–Registered Nurse, PhD-Physiotherapist, PhD–Occupational Therapist or equivalent) within the first five (5) years of their first faculty appointment in the establishment of their careers.

Research Areas

Priority areas include basic and translational research programs in chronic respiratory disease, including but not limited to chronic obstructive pulmonary disease, asthma, cough, chronic bronchitis, bronchiectasis, cystic fibrosis, bronchopulmonary dysplasia, alpha-1 antitrypsin deficiency, interstitial lung disease, and idiopathic pulmonary fibrosis.

For more information, please consult the Canadian Lung Association website and ResearchNet. 

Please contact Sue Haydt, Research Grants Facilitator, for more information (Susan.Haydt@dal.ca)

Deadlines:

Agency Registration Deadline – June 26, 2019
Internal Application Deadline – July 24, 2019
Agency Application Deadline - July 31, 2019